Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen J Beswick

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Cells|July 11, 2025
MK2 Inhibition as a Novel Treatment for Fibrosis in Primary Sclerosing Cholangitis via an IL-22-Dependent MechanismCody S Howe, Ellen J Beswick
World Journal of Gastroenterology|June 18, 2009
CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tractEllen J Beswick, Victor E Reyes
Infection and Immunity|May 14, 2008
Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptorEllen J Beswick, Victor E Reyes
British Journal of Cancer|November 14, 2022
Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophilsDamian Jacenik, Ioannis Karagiannidis, Ellen J Beswick
World Journal of Gastroenterology|September 29, 2006
H pylori and host interactions that influence pathogenesisEllen J Beswick, Giovanni Suarez, Victor E Reyes
Helicobacter|September 11, 2012
Inflammation, immunity, and vaccines for Helicobacter pylori infectionAlojz Ihan, Irina V Pinchuk, Ellen J Beswick
World Journal of Gastroenterology|September 29, 2006
Immune response to H. pyloriGiovanni Suarez, Victor E Reyes, Ellen J Beswick
The Journal of Infectious Diseases|April 16, 2003
Comparative studies of glycosaminoglycan involvement in Chlamydia pneumoniae and C. trachomatis invasion of host cellsEllen J Beswick, Anna Travelstead, Morris D Cooper
International Journal of Molecular Sciences|November 11, 2022
MK2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Mediated by Macrophages and Metabolomic FactorsDamian Jacenik, Eric J Lebish, Ellen J Beswick
Frontiers in Immunology|July 7, 2023
MK2 drives progression of pancreas and colon cancers by suppressing CD8<sup>+</sup> T cell cytotoxic function and is a potential immunotherapy targetDamian Jacenik, Eric J Lebish, Ellen J Beswick
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Cells|July 11, 2025
MK2 Inhibition as a Novel Treatment for Fibrosis in Primary Sclerosing Cholangitis via an IL-22-Dependent MechanismCody S Howe, Ellen J Beswick
World Journal of Gastroenterology|June 18, 2009
CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tractEllen J Beswick, Victor E Reyes
Infection and Immunity|May 14, 2008
Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptorEllen J Beswick, Victor E Reyes
British Journal of Cancer|November 14, 2022
Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophilsDamian Jacenik, Ioannis Karagiannidis, Ellen J Beswick
World Journal of Gastroenterology|September 29, 2006
H pylori and host interactions that influence pathogenesisEllen J Beswick, Giovanni Suarez, Victor E Reyes
Helicobacter|September 11, 2012
Inflammation, immunity, and vaccines for Helicobacter pylori infectionAlojz Ihan, Irina V Pinchuk, Ellen J Beswick
World Journal of Gastroenterology|September 29, 2006
Immune response to H. pyloriGiovanni Suarez, Victor E Reyes, Ellen J Beswick
The Journal of Infectious Diseases|April 16, 2003
Comparative studies of glycosaminoglycan involvement in Chlamydia pneumoniae and C. trachomatis invasion of host cellsEllen J Beswick, Anna Travelstead, Morris D Cooper
International Journal of Molecular Sciences|November 11, 2022
MK2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Mediated by Macrophages and Metabolomic FactorsDamian Jacenik, Eric J Lebish, Ellen J Beswick
Frontiers in Immunology|July 7, 2023
MK2 drives progression of pancreas and colon cancers by suppressing CD8<sup>+</sup> T cell cytotoxic function and is a potential immunotherapy targetDamian Jacenik, Eric J Lebish, Ellen J Beswick
Pageof 7